Call Options Transactions Made in Q3 2024 in Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the institutional ownership of Bridge Bio Pharma, Inc. (BBIO) during Q3 2024. The information is specifically focused on institutions that hold call options of BridgeBio Pharma, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
CALL |
2MNew |
$47.8M - $62.5M
|
2M
$58.1M
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
BUY
|
CALL |
246K+ 6.36% |
$5.88M - $7.69M
|
4.11M
$119M
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
147K+ 4.91% |
$3.51M - $4.59M
|
3.14M
$91.3M
|
|
Nov 07, 2024
Q3 2024
|
Lmr Partners LLP
London, X0 |
BUY
|
CALL |
80K+ 400.0% |
$1.91M - $2.5M
|
100K
$2.91M
|
|
Nov 14, 2024
Q3 2024
|
Balyasny Asset Management LLC
Chicago, IL |
BUY
|
CALL |
69.9KNew |
$1.67M - $2.19M
|
69.9K
$2.03M
|
|
Nov 13, 2024
Q3 2024
|
Peak6 Investments LLC
Chicago, IL |
BUY
|
CALL |
37K+ 211.43% |
$885K - $1.16M
|
54.5K
$1.58M
|
|
Nov 13, 2024
Q3 2024
|
Gts Securities LLC
New York, NY |
BUY
|
CALL |
22.2KNew |
$531K - $695K
|
22.2K
$646K
|
|
Oct 18, 2024
Q3 2024
|
Fny Investment Advisers, LLC
|
SELL
|
CALL |
-56- 53.33% |
$1.34K - $1.75K
|
49
$1.42K
|
|
Nov 14, 2024
Q3 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
CALL |
-7.7K- 27.11% |
$184K - $241K
|
20.7K
$602K
|
|
Nov 14, 2024
Q3 2024
|
Wolverine Trading, LLC
Chicago, IL |
SELL
|
CALL |
-15.9K- 26.68% |
$380K - $498K
|
43.7K
$1.27M
|
|
Oct 30, 2024
Q3 2024
|
Belvedere Trading LLC
|
SELL
|
CALL |
-17.3K- 55.45% |
$414K - $541K
|
13.9K
$404K
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-81.5K- 26.04% |
$1.95M - $2.55M
|
232K
$6.73M
|
|
Nov 14, 2024
Q3 2024
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
CALL |
-234K- 44.5% |
$5.59M - $7.31M
|
291K
$8.47M
|